Inhaled & Pulmonary Delivery Programs

About Nanoform Finland

Nanoform Finland is a public biotech company specializing in nanonizing active pharmaceutical ingredients (APIs) to overcome solubility challenges, a major hurdle in drug development. Its core CESS® technology creates nano-sized particles without harsh chemicals, enhancing drug absorption and enabling new delivery routes. The company operates a client-centric business model, partnering with drug developers globally to improve existing compounds and rescue promising molecules that failed due to poor solubility.

Therapeutic Areas